LncRNA GAS5 inhibits proliferation and progression of prostate cancer by targeting miR-103 through AKT/mTOR signaling pathway.

Xue D, Zhou C, Lu H, Xu R, Xu X, He X.

Open source

DOI
10.1007/s13277-016-5429-8
Published
2016-10-14
Container
Tumour Biol
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13277-016-5429-8,
  title = {LncRNA GAS5 inhibits proliferation and progression of prostate cancer by targeting miR-103 through AKT/mTOR signaling pathway.},
  author = {Xue D and  Zhou C and  Lu H and  Xu R and  Xu X and  He X.},
  year = {2016},
  journal = {Tumour Biol},
  doi = {10.1007/s13277-016-5429-8},
  url = {https://doi.org/10.1007/s13277-016-5429-8}
}

RIS

TY  - JOUR
TI  - LncRNA GAS5 inhibits proliferation and progression of prostate cancer by targeting miR-103 through AKT/mTOR signaling pathway.
AU  - Xue D
AU  -  Zhou C
AU  -  Lu H
AU  -  Xu R
AU  -  Xu X
AU  -  He X.
PY  - 2016
JO  - Tumour Biol
DO  - 10.1007/s13277-016-5429-8
UR  - https://doi.org/10.1007/s13277-016-5429-8
ER  - 

APA

D, X., C, Z., H, L., R, X., X, X., & X., H. (2016). LncRNA GAS5 inhibits proliferation and progression of prostate cancer by targeting miR-103 through AKT/mTOR signaling pathway.. Tumour Biol. https://doi.org/10.1007/s13277-016-5429-8

Source records